Screening for HbA1c-defined prediabetes and diabetes in an at-risk greek population: Performance comparison of random capillary glucose, the ADA diabetes risk test and skin fluorescence spectroscopy

Diabetes Research and Clinical Practice

Volumn 100, Issue 1, 2013, Pages 39-45

  Tentolouris, Nicholas ^a   Lathouris, Panagiotis ^b   Lontou, Stavroula ^a   Tzemos, Kostas ^c   Maynard, John ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Social Insurance Institute   (Greece)

^c VeraLight   (United States)

Author keywords

A1C; Advanced glycation endproducts; Diabetes prevention; Diabetes risk test; Diabetes screening; Noninvasive; Prediabetes screening; Random capillary glucose; Scout DS; Skin fluorescence spectroscopy

Indexed keywords

HEMOGLOBIN A1C;

ADA DIABETES RISK TEST; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYSGLYCEMIA; FEMALE; GREECE; HEMOGLOBIN DETERMINATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RANDOM CAPILLARY GLUCOSE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN FLUORESCENCE SPECTROSCOPY; VALIDITY; WAIST CIRCUMFERENCE;

AREA UNDER CURVE; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CAPILLARIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; GLUCOSE TOLERANCE TEST; GREECE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; WAIST CIRCUMFERENCE;

EID: 84876742233     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.01.002     Document Type: Article

References (34)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. International Diabetes Federation IDF Diabetes Atlas 2011, International Diabetes Federation, Brussels, Belgium. http://www.idf.org/diabetesatlas/5e/detailed-data-and-interactive-map, 5th ed.
3. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. Diabetes Prevention Program Research, Group.
4. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
5. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012, 35:723-730. The Diabetes Prevention Program Research Group.
6. Engelgau M.M., Thompson T.J., Smith P.J., Herman W.H., Aubert R.E., Gunter E.W., et al. Screening for diabetes mellitus in adults: the utility of random capillary blood glucose measurements. Diabetes Care 1995, 18:463-466.
7. Ealovega M.W., Bahman P., Tabaei B.P., Brandle M., Burke R., Herman W.H. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004, 27:9-12.
8. Zhang P., Engelgau M.M., Valdez R., Cadwell B., Benjamin S.M., Narayan K.M.V. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care 2005, 28:1321-1325.
9. Ziemer D.C., Kolm P., Foster J.K., Weintraub W.S., Vaccarino V., Rhee M.K., et al. Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 2008, 23:528-535.
10. Somannavar S., Ganesan A., Deepa M., Datta M., Mohan V. Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India. Diabetes Care 2009, 32:641-643.
11. Rolka D.B., Narayan K.M.V., Thompson T.J., Goldman D., Lindenmayer J., Alich K., et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 2001, 24:1899-1903.
12. Buijsse B., Simmons R.K., Griffin S.J., Schulze M.B. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011, 33:46-62.
13. Collins G.S., Mallett S., Omar O., Yu L.M. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011, 9:1-14.
14. Robinson C.A., Agarwal G., Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. Chronic Dis Inj Can 2011, 32:19-31.
15. Maynard J.D., Rohrscheib M., Way J.F., Nguyen C.M., Ediger M.N. Noninvasive type 2 diabetes screening. Diabetes Care 2007, 30:1120-1124.
16. Ediger M.N., Olson B.P., Maynard J.D. Noninvasive optical screening for diabetes. J Diabetes Sci Technol 2009, 3:776-780.
17. Hull E., Ediger M., Unione A., Deemer E., Stroman M., Baynes J. Noninvasive, optical detection of diabetes: model studies with porcine skin. Opt Express 2004, 12:4496-4510.
18. Dieuwke C.B., de Ranitz-Greven W.L., de Valk H.W. Diabetes Technol Ther 2011, 13(7):773-779.
19. Yoshino J., Mills K., Yoon M.J., Imai S.I. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 2011, 14:528-536.
20. Heikal A. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 2010, 4:241-263.
21. Bang H., Edwards A.M., Bomback A.S., Ballantyne C.M., Brillon D., Callahan M.A., et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med 2009, 151:775-783.
22. American Diabetes Association Standards of Medical Care in Diabetes-2012. Diabetes Care 2012, 35(Suppl. 1):S11-S63.
23. College of American Pathologists. GH2 Survey Data. http://www.ngsp.org/CAP/CAP12a.pdf.
24. Slingerland R.J., Lenters-Westra E. Six of eight hemoglobin A1C point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010, 56:44-52.
25. Standards of medical care in diabetes-2010. Diabetes Care 2010, 33:S11-S61. American Diabetes, Association.
26. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
27. Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011, 93:99-309.
28. Hare M.J.L., Shaw J.E., Zimmet P.Z. Current controversies in the use of haemoglobin A1C. J Intern Med 2012, 271:227-236.
29. Mann D.M., Carson A.P., Shimbo D., Fonseca V., Fox C.S., Munther P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S adults. Diabetes Care 2010, 33:2190-2195.
30. Marini M.A., Succurro E., Castaldo E., Cufone S., Arturi F., Sciacqua A., et al. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012, 35:1144-1149.
31. Lathouris P., Tzemos K., Maynard J., Tentolouris N. Comparison of the Leicester risk assessment score, FINDRISC and SCOUT DS for diabetes screening in an At-risk greek population. Diabetologia 2012, 55(Suppl1):S158.
32. Chatterjee R., Lipscomb J., Narayan V.K.M., Phillips L.S. Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 2010, 33:1484-2149.
33. Anjana R.M., Pradeepa R., Deepa M., Datta M., Sudha V., Unnikrishnan R., et al. The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) Study: methodological details. J Diabetes Sci Technol 2011, 5:906-914.
34. Christensen J.O., Sandbæk A., Lauritzen T., Borch-Johnsen J. Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004, 47:1566-1573.